Glycerin

Glycerin

SCHEMBL4294890

CC(C)(C)[SiH](c1ccccc1)c1ccccc1.OCC(O)CO

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
CYP1A2 P05177 2/20 0.36
KDM4E B2RXH2 1/20 0.36
AGTR1 P30556 1/20 0.36
RIPK1 Q13546 1/20 0.35
ALDH1A1 P00352 2/20 0.35
TRPA1 O75762 4/20 0.34
ADRA2A P08913 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CA1 P00915 1/20 0.33
TAAR1 Q96RJ0 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398 0.81 MAPK1 (0.36) LMNAALDH1A1CYP2D6CYP2C19HIF1A
Hydrochloric Acid SCHEMBL1295227 0.79 MAPK1 (0.35) LMNAALDH1A1CYP2D6SLC6A2TAAR1
SCHEMBL30367101 0.79 MAPK1 (0.35) LMNAALDH1A1CYP2D6SLC6A2TAAR1
Phosphoric Acid SCHEMBL28944728 0.74 TSHR (0.41) ALDH1A1ALOX15
SCHEMBL27535279 0.71 TAAR1 (0.47) LMNACYP1A2KDM4EAGTR1RIPK1
Toluene SCHEMBL11058611 0.70 LMNA (0.55) LMNACYP1A2KDM4EAGTR1ALDH1A1
Glycerin SCHEMBL27483108 0.69 KCNN4 (0.46) LMNACYP1A2KDM4EAGTR1ALDH1A1
Toluene SCHEMBL11701931 0.69 LMNA (0.52) LMNACYP1A2KDM4EAGTR1ALDH1A1
Phenol SCHEMBL28128789 0.69 CA12 (0.52) LMNACYP1A2KDM4EAGTR1ALDH1A1
Glycerin SCHEMBL28239880 0.68 LMNA (0.64) LMNACYP1A2KDM4EAGTR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221684-A1 Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof TRUSTEES OF BOSTON UNIVERSITY (US) 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221684-A1 Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof ANXA6, STING1, ADM2 LMNA 967/4885CYP1A2 4706/4885KDM4E 2973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.